Ligand Pharmaceuticals Earnings Loss from Eq. Investments (Quarterly) Analysis

Ligand Pharmaceuticals, Inc. (LGND)

203.61 +5.76 (+2.91%) USD | NASDAQ | Mar 02, 11:05

View Earnings Loss from Eq. Investments (Quarterly) for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Earnings Loss from Eq. Investments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Earnings Loss from Eq. Investments (Quarterly) Benchmarks

Start Trial